Stanley B. Fiel

Stanley B. Fiel is a Venture Advisor at Israel Biotech Fund. Dr. Fiel is a distinguished physician and author of numerous published works on various topics relating to pulmonary and critical care medicine. Since 1978, Dr. Fiel has held key hospital appointments including Chief of the Division of Pulmonary / Critical Care Medicine at Drexel University College of Medicine and Hahnemann University in Philadelphia.

Dr. Fiel currently serves on the Advisory Board and Speaker’s Bureau with Pfizer, GlaxoSmithKline, Gilead, and Novartis. He has been a consultant for GlaxoSmithKline, Novartis, Pfizer, Gilead, and Vertex. He has received research grants from the NIH, Cystic Fibrosis Foundation, and various pharmaceutical companies.